Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6178419rdf:typepubmed:Citationlld:pubmed
pubmed-article:6178419lifeskim:mentionsumls-concept:C0020538lld:lifeskim
pubmed-article:6178419lifeskim:mentionsumls-concept:C0042036lld:lifeskim
pubmed-article:6178419lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:6178419lifeskim:mentionsumls-concept:C0859036lld:lifeskim
pubmed-article:6178419lifeskim:mentionsumls-concept:C0005149lld:lifeskim
pubmed-article:6178419lifeskim:mentionsumls-concept:C0680730lld:lifeskim
pubmed-article:6178419lifeskim:mentionsumls-concept:C0243102lld:lifeskim
pubmed-article:6178419lifeskim:mentionsumls-concept:C1148554lld:lifeskim
pubmed-article:6178419lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:6178419pubmed:issue1lld:pubmed
pubmed-article:6178419pubmed:dateCreated1982-9-10lld:pubmed
pubmed-article:6178419pubmed:abstractTextActivity of alanine aminopeptidase (AAP), aryl sulphatase A (ASA) beta-glucoronidase (beta-GA) and the concentration of beta 2-microglobulin in urine was determined in 12 patients with chronic diffuse glomerulonephritis and in 16 patients with essential hypertension. The control group consisted of 6 practically healthy persons. The AAP activity in urine of patients with chronic glomerulonephritis was significantly higher than that in healthy subjects. Renal excretion of lysosomal enzymes (ASA, beta-GA) appeared to be less expressed; no significant differences as regard to their excretion were noted between the above mentioned groups. Concentrations of beta 2-microglobulin in urine of patients with chronic glomerulonephritis 6 times exceeded its concentration in healthy persons and in hypertensive patients, more than 3 times as much. Determination of the enzyme activity and beta 2-microglobulin concentration in urine may serve a test in differential diagnosis, for evaluation of the treatment efficiency of patients with chronic glomerulonephritis accompanied by arterial hypertension and those suffering from essential hypertension.lld:pubmed
pubmed-article:6178419pubmed:languageruslld:pubmed
pubmed-article:6178419pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6178419pubmed:citationSubsetIMlld:pubmed
pubmed-article:6178419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6178419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6178419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6178419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6178419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6178419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6178419pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6178419pubmed:statusMEDLINElld:pubmed
pubmed-article:6178419pubmed:issn0201-7369lld:pubmed
pubmed-article:6178419pubmed:authorpubmed-author:MishchenkoB...lld:pubmed
pubmed-article:6178419pubmed:authorpubmed-author:KlimenkoV SVSlld:pubmed
pubmed-article:6178419pubmed:issnTypePrintlld:pubmed
pubmed-article:6178419pubmed:volume5lld:pubmed
pubmed-article:6178419pubmed:ownerNLMlld:pubmed
pubmed-article:6178419pubmed:authorsCompleteYlld:pubmed
pubmed-article:6178419pubmed:pagination43-5lld:pubmed
pubmed-article:6178419pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:6178419pubmed:meshHeadingpubmed-meshheading:6178419-...lld:pubmed
pubmed-article:6178419pubmed:meshHeadingpubmed-meshheading:6178419-...lld:pubmed
pubmed-article:6178419pubmed:meshHeadingpubmed-meshheading:6178419-...lld:pubmed
pubmed-article:6178419pubmed:meshHeadingpubmed-meshheading:6178419-...lld:pubmed
pubmed-article:6178419pubmed:meshHeadingpubmed-meshheading:6178419-...lld:pubmed
pubmed-article:6178419pubmed:meshHeadingpubmed-meshheading:6178419-...lld:pubmed
pubmed-article:6178419pubmed:meshHeadingpubmed-meshheading:6178419-...lld:pubmed
pubmed-article:6178419pubmed:meshHeadingpubmed-meshheading:6178419-...lld:pubmed
pubmed-article:6178419pubmed:meshHeadingpubmed-meshheading:6178419-...lld:pubmed
pubmed-article:6178419pubmed:meshHeadingpubmed-meshheading:6178419-...lld:pubmed
pubmed-article:6178419pubmed:meshHeadingpubmed-meshheading:6178419-...lld:pubmed
pubmed-article:6178419pubmed:meshHeadingpubmed-meshheading:6178419-...lld:pubmed
pubmed-article:6178419pubmed:meshHeadingpubmed-meshheading:6178419-...lld:pubmed
pubmed-article:6178419pubmed:meshHeadingpubmed-meshheading:6178419-...lld:pubmed
pubmed-article:6178419pubmed:meshHeadingpubmed-meshheading:6178419-...lld:pubmed
pubmed-article:6178419pubmed:meshHeadingpubmed-meshheading:6178419-...lld:pubmed
pubmed-article:6178419pubmed:meshHeadingpubmed-meshheading:6178419-...lld:pubmed
pubmed-article:6178419pubmed:year1982lld:pubmed
pubmed-article:6178419pubmed:articleTitle[Determination of enzyme activity and beta 2-microglobulin concentration in the urine in chronic diffuse glomerulonephritis and hypertension].lld:pubmed
pubmed-article:6178419pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6178419pubmed:publicationTypeEnglish Abstractlld:pubmed